US 8652512
Nebulized liposomes for the pulmonary application of drug compounds
granted A61KA61K9/0078A61K9/1271
Quick answer
US patent 8652512 (Nebulized liposomes for the pulmonary application of drug compounds) held by United Therapeutics Corporation expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K9/0078, A61K9/1271